Related Experiment Videos
[Acute lymphocytic leukemia (L1) preceded by hypercalcemia].
1Second Department of Internal Medicine, Miyazaki Medical College.
Summary
This case study highlights a rare instance of hypercalcemia in acute lymphocytic leukemia (ALL). Treatment effectively resolved both the leukemia and high calcium levels, offering insights into this complex condition.
Area of Science:
- Oncology
- Endocrinology
- Hematology
Background:
- Hypercalcemia is an uncommon complication of acute leukemia.
- Parathyroid hormone-related protein (PTHrP) is a known cause of hypercalcemia.
Observation:
- A 37-year-old female presented with hypercalcemia, nausea, vomiting, and back pain, initially without evidence of leukemia.
- Elevated PTHrP levels and osteoporosis were noted.
- Acute lymphocytic leukemia (ALL) was diagnosed five months later with 98% lymphoblasts in bone marrow.
Findings:
- Treatment with standard chemotherapy (vincristine, daunorubicin, prednisolone, L-asparaginase) achieved complete remission.
- Serum calcium levels normalized following successful leukemia treatment.
- The hypercalcemia was attributed to PTHrP secreted by tumor cells, increasing bone absorption.
Implications:
- This case underscores the importance of investigating hypercalcemia in leukemia patients.
- Understanding the role of PTHrP in ALL-associated hypercalcemia can guide diagnosis and management.
- This rare presentation provides valuable data for the etiology of hypercalcemia in acute leukemia.